Navigation Links
The Pittsburgh Life Sciences Greenhouse Adds Life Sciences Veterans to Executive Program
Date:10/6/2009

PITTSBURGH, Oct. 6 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to the region's life sciences enterprises, announced that two nationally recognized executives have joined the PLSG as Executives in Residence (EIR).

Joining the PLSG as EIRs are Dave Mawhinney and Stephen A. Bollinger.

Mr. Mawhinney possesses a vast background in marketing, product development, operations and entrepreneurial ventures including four healthcare IT start-ups. In addition to his executive management experience in those start-ups; Premier Health Exchange, Hawk Medical Supply Corp., and IndustryNet Corporation, he worked for the venture capital firm PNC Technology Investors and Bayer Corporation. Mr. Mawhinney holds a Bachelor of Science Degree in Physics from Indiana University of Pennsylvania and a Masters Degree in Business Administration from Carnegie Mellon University.

Mr. Bollinger brings extensive experience with medical device companies where he applied his background in marketing, product management and operations. In addition to his senior management experience with these companies, he also worked for the venture capital firm Highland Capital Partners where he held the position of Executive-in-Residence, helping to build companies and identify investments in the healthcare segment of that firm. Mr. Bollinger holds a Bachelor of Science Degree in Mechanical Engineering from the United States Military Academy and a Masters Degree in Business Administration from Oklahoma City University.

"Our Executive Program has responded to the life sciences community's demand; providing executive talent to help form companies; subject matter experts to guide companies; executives to run companies; and program managers and directors to help companies grow," said John W. Manzetti, PLSG's President and Chief Executive Officer.

Since inception, 30 life sciences experts have participated in the PLSG Executive Program. Seven of those executives remain active in the PLSG Executive Program and twenty remain in western Pennsylvania's life sciences community -- twelve as CEOs and eight as C-Suite and Executive Team members.

"The addition of these two accomplished professionals builds on the credibility of the Executive Program and the investment interest that the PLSG portfolio has received at the national venture capital level," added Jim Jordan, PLSG's Vice President & Chief Investment Officer. "Our national reputation for attracting world-class life sciences talent will help insure the continued growth of the region's economic base and life sciences sector from concept to commercialization.(TM)"

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The Pittsburgh Life Sciences Greenhouse (PLSG) provides capital investments and customized company formation and business growth services to western Pennsylvania's life sciences enterprises. The PLSG supports biosciences companies with promising innovations in the following concentrations: Biotechnology Tools, Diagnostics, Healthcare IT, Medical Devices and Therapeutics. The PLSG is propelling the sustainable growth of the region's life sciences economy by accelerating research and technology commercialization with seed and early-stage companies; connecting investors with their Investment Portfolio companies; expanding established life sciences ventures and relocating biomedical companies to Pennsylvania. For more information, visit www.plsg.com.

SOURCE Pittsburgh Life Sciences Greenhouse


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio
2. The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio
3. The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors
4. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
5. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
6. The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments
7. Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
8. Pittsburgh Region Middle School Students Participate in Hands-on Tissue Engineering Summer Camp
9. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
10. Pittsburgh Technology Council Announces Technology 50
11. Opening Dedication of the New John G. Rangos Sr. Research Center at the New Childrens Hospital of Pittsburgh of UPMC Campus in Lawrenceville
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017 Sinovac Biotech Ltd. ("Sinovac" ... in China , today announced that its board ... expiration date of the plan from March 27, 2017 to March ... About Sinovac Biotech Ltd. ... Sinovac Biotech Ltd. is a ...
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed president, ... viscous and elastic characteristics when deformed, which is identical to how the human ... absorb compressive forces and return to its natural state along a hysteresis curve, ...
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
Breaking Biology Technology:
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... MELBOURNE , Australia , March ... clinical study data at the prestigious World Lung Imaging ... Dr. Andreas Fouras , was invited to deliver ... and pulmonary medicine. This globally recognised event brings together ... and share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):